Medtronic builds out chronic pain continuum with Viaverte, SPR
· shani alexander
AI Briefing
- • Medtronic launches Viaverte BVNA system to treat chronic pain.
- • Acquisition of SPR Therapeutics strengthens Medtronic's pain care capabilities.
- • Combined offerings expand Medtronic's presence across the chronic pain continuum.
Context
Medtronic plc has launched the Viaverte basivertebral nerve ablation system and completed the acquisition of SPR Therapeutics Inc. These moves expand Medtronic's chronic pain treatment options. The company now offers a broader range of solutions for patients.
The expansion of Medtronic's chronic pain offerings matters as it strengthens the company's ability to treat patients across the pain care continuum.
Advertisement